MedPath

VitNovo, Inc.

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients

Phase 1
Completed
Conditions
Type2 Diabetes
Interventions
Drug: DCB-DM101
First Posted Date
2017-01-26
Last Posted Date
2018-10-16
Lead Sponsor
VitNovo, Inc.
Target Recruit Count
28
Registration Number
NCT03033433
Locations
🇨🇳

Tri-Service General Hospital, Taipei, Taiwan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.